In this task, you are given a text of many news articles seperated by special token "|||||". Your task is to summarize them.

Pricey specialty drugs helped CVS Health cope with tobacco withdrawal and top analyst expectations in the second quarter. 
  
 FILE - This March 17, 2014 file photo shows a CVS/Pharmacy in Dormont, Pa. CVS Health reports quarterly financial results on Tuesday, Aug. 4, 2015. (AP Photo/Gene J. Puskar, File) (Associated Press) 
  
 But the nation's second-largest drugstore chain also narrowed its full-year earnings outlook and issued a third-quarter forecast that fell short of Wall Street's expectations. 
  
 Its stock fell 2.5 percent in trading Tuesday. 
  
 The Woonsocket, Rhode Island, company said that revenue from its biggest business, its pharmacy benefits management segment, jumped 12 percent in the second quarter to more than $24 billion, spurred in part by specialty drugs. 
  
 These complex medications treat certain forms of cancer and hepatitis C, among other conditions. They often represent treatment breakthroughs but can cost considerably more than other prescriptions. Use of these drugs is soaring, and health insurers, employers and other bill payers are relying more on companies like CVS Health to help restrain this growth. 
  
 Revenue from the company's retail drugstore segment inched up only 2 percent to $17.2 billion in part because sales from the front-end of its stores, or the area outside the pharmacy, plunged 7.8 percent, at established locations. 
  
 CVS Health runs 7,870 drugstores. The front-end figure from those stores would have been flat if CVS hadn't pulled tobacco products from its shelves nearly a year ago. The drugstore chain actually helped profitability by dumping thin-margin tobacco products, but its executives knew they would take a sales hit because smokers often grab other products when they stop in for their next pack. 
  
 The company dropped tobacco anyway because it is trying to burnish its image as a health care services provider. The drugstore chain runs nearly 1,000 walk-in clinics in its stores and has bulked up on healthy foods and the number of health care and beauty products it provides. It also plans to expand its reach into health care with a $1.9 billion deal to purchase the pharmacy and clinic business of the retail giant Target Corp. 
  
 CEO Larry Merlo told analysts that the Target deal helps expand his company's presence west of the Mississippi River "in a very, very capital efficient way," without having to build new stores. 
  
 Overall, CVS Health earnings rose 2 percent to $1.27 billion in the second quarter while revenue rose more than 7 percent to $37.17 billion. 
  
 Adjusted earnings totaled $1.22 per share, excluding costs tied to the Target deal and the company's pending $10 billion acquisition of pharmaceutical distributor Omnicare. 
  
 Analysts expected, on average, earnings of $1.20 per share on $37.16 billion in revenue, according to Zacks Investment Research. 
  
 CVS Health has scaled back the number of shares it intends to buy back this year, choosing instead to spend the money on its pending acquisitions. Partially because of that, it tightened its 2015 earnings forecast to $5.11 to $5.18 per share from a previous range of $5.08 to $5.19. 
  
 Analysts expect an average of $5.16 per share, according to FactSet. 
  
 For the current quarter, CVS Health expects adjusted earnings of $1.27 to $1.30 per share, while analysts forecast $1.37 per share. 
  
 Shares of Woonsocket, Rhode Island-based CVS Health dropped $2.86 to $109.96 on Tuesday. The stock hit an all-time high price of $113.65 last week and has increased 42 percent in the last 12 months. ||||| Sales at CVS Health are getting "smoked." 
  
 Last September, CVS became the first major pharmacy chain in America to stop selling cigarettes and other tobacco products in its stores. The drug store chain said it was the right thing to do -- even though it would hurt sales. 
  
 Now CVS (CVS) is detailing just how much the tobacco ban is impacting the company. While prescription sales continue to rise, general merchandise sales tumbled nearly 8% last quarter on a same-store basis. 
  
 CVS blamed the slump on the tobacco ban. The company said front-store sales would have been flat compared with the year before if they didn't make the change. 
  
 Conlumino analyst Stephen Ward believes that while the smoke ban was a "sensible move" for CVS's brand, it has come at a cost. "It has most certainly affected sales both directly, and indirectly, through the reduction in impulse purchases that tobacco customers made," Ward wrote in a report. 
  
 Related: Smoking is not cool. But cigarette stocks are hot 
  
 CVS stock dropped 3% on Tuesday after the company sounded cautious about the current quarter. The bar had been set very high as CVS shares have soared 40% over the past year and hit all-time highs just last week. 
  
 $2 billion hit to sales: The decline in front-store sales stands in stark contrast to the much larger prescription business. CVS said pharmacy sales jumped over 4% last quarter as Americans continue to ramp up health care spending. 
  
 The fact CVS is hurting a bit from its tobacco ban is not shocking. When CVS first announced the move in February 2014, it warned sales could take a $2 billion hit. That's just a fraction of the $139 billion in annual sales CVS generates, but it's not nothing. 
  
 "By eliminating the sale of cigarettes and tobacco products in our stores, we can make a difference in the health of all Americans," CVS CEO Larry Merlo said when the ban took effect last September. 
  
 To coincide with the smoke ban, CVS also changed its name from CVS Caremark to CVS Health. 
  
 Related: Tax the poor! States raise sales, cigarette taxes 
  
 CVS has room for improvement: CVS is clearly betting the move will improve its brand image, especially among the growing population of Americans who don't smoke. Now the company is focused on selling more profitable items like beauty products. 
  
 CVS said it once again gained market share in its health and beauty categories last quarter. 
  
 Ward, the Conlumino analyst, believes CVS can offset its tobacco challenges by taking a page out of Walgreen's (WBA) playbook. He said CVS needs to step up its game by improving the general shopping experience, especially in the beauty category. 
  
 "The trick for CVS is to match momentum in retail with the momentum it has built up in its pharmacy business," Ward wrote. |||||
CVS banned cigarettes from its stores last fall and last month showed it's sticking to its anti-tobacco stance, believing it's the right thing to do. The company's sales say otherwise. Though CVS' prescription sales climbed 4% in the second quarter, sales outside the pharmacy fell by almost 8%—a drop CVS attributes exclusively to its cigarette ban, reports CNNMoney. The company says it's focusing on health and beauty products, which are gaining market share, but the drug store isn't bleeding. Overall, earnings rose 2% to $1.27 billion while revenue jumped 7% to $37.17 billion, per the AP.